Elsie Biotechnologies Announced A Research Collaboration Agreement With GSK To Advance The Discovery And Development Of Elsie's Oligonucleotide Discovery Platform; Deal Terms Were Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Elsie Biotechnologies has entered into a research collaboration agreement with GSK to advance the discovery and development of Elsie's Oligonucleotide Discovery Platform. The deal includes an upfront payment to Elsie and potential development and commercial milestones. The terms of the deal were not disclosed.
July 10, 2023 | 11:11 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GSK has entered into a research collaboration agreement with Elsie Biotechnologies. This could potentially lead to advancements in GSK's product pipeline, depending on the success of the research.
The partnership with Elsie Biotechnologies could potentially lead to advancements in GSK's product pipeline. This could have a positive impact on GSK's stock in the short term, depending on the success of the research and the market's perception of the deal.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70